User menu

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

Bibliographic reference De Roock, Wendy ; Piessevaux, Hubert ; Claes, Bart ; De Schutter, Jef ; Biesmans, Bart ; et. al. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis. In: The Lancet Oncology, Vol. 11, no. 8, p. 753-762 (2010)
Permanent URL http://hdl.handle.net/2078.1/33583